| 2025-03-17 |
详情>>
股本变动：
变动后总股本5240.28万股
变动原因 ▼▲
- 原因：
- From October 31, 2024 to January 31, 2025
Vesting of restricted stock units
|
| 2025-03-17 |
详情>>
业绩披露：
2025年中报每股收益-0.09美元,归母净利润-491.1万美元,同比去年增长49.25%
|
| 2025-01-16 |
详情>>
内部人交易：
Radoff Bradley Louis等共交易3笔
|
| 2024-12-16 |
详情>>
业绩披露：
2025年一季报每股收益-0.07美元,归母净利润-337.6万美元,同比去年增长48.97%
|
| 2024-11-27 |
股东大会：
将于2025-01-15召开股东大会
会议内容 ▼▲
- 1.To elect Steven J. Pully, Bradley L. Radoff, Jon Couchman and Kara Cannon to the Company’s Board of Directors (the “Board”) to hold office for a term ending as of our 2025 annual meeting of shareholders, and until each such director’s successor is elected and qualified;
2.To approve, by a nonbinding advisory vote, the compensation of the Company’s Named Executive Officers (the “Advisory Proposal”);
3.To ratify the Company’s appointment of EisnerAmper LLP to serve as the Company’s independent registered public accounting firm for the Company’s fiscal year ending July 31, 2025 (the “Auditor Proposal”);
4.To hold an advisory vote on the frequency of holding the shareholder advisory vote to approve executive compensation (the “Frequency Proposal”);
5.To transact such other business as may properly come before the Annual Meeting.
|
| 2024-10-29 |
详情>>
业绩披露：
2024年年报每股收益-0.51美元,归母净利润-2607.8万美元,同比去年增长-228.54%
|
| 2024-06-13 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.25美元,归母净利润-1269.7万美元,同比去年增长65.81%
|
| 2024-03-13 |
详情>>
业绩披露：
2024年中报每股收益-0.19美元,归母净利润-967.7万美元,同比去年增长55.92%
|
| 2023-12-21 |
股东大会：
将于2024-01-31召开股东大会
会议内容 ▼▲
- 1.To elect Steven J. Pully, Bradley L. Radoff, Mary Tagliaferri, M.D., and Kara Cannon to the Company’s Board of Directors (the “Board”) to hold office for a term ending as of our 2024 annual meeting of shareholders, and until each such director’s successor is elected and qualified;
2.To approve, by a nonbinding advisory vote, the compensation of the Company’s Named Executive Officers (the “Advisory Proposal”);
3.To ratify the Company’s appointment of EisnerAmper LLP to serve as the Company’s independent registered public accounting firm for the Company’s fiscal year ending July 31, 2024 (the “Auditor Proposal”);
4.To transact such other business as may properly come before the Annual Meeting.
|
| 2023-12-15 |
详情>>
业绩披露：
2024年一季报每股收益-0.13美元,归母净利润-661.6万美元,同比去年增长37.79%
|
| 2023-11-03 |
详情>>
业绩披露：
2023年年报每股收益0.41美元,归母净利润2028.80万美元,同比去年增长211.10%
|
| 2023-06-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.76美元,归母净利润-3714.2万美元,同比去年增长-277.92%
|
| 2023-04-24 |
股东大会：
将于2023-05-22召开股东大会
会议内容 ▼▲
- 1.“FOR” the approval of the Asset Sale and adoption of the Asset Purchase Agreement (the “Asset Sale Proposal”);
2.“FOR” the proposal to adjourn the Special Meeting to solicit additional proxies if there are insufficient votes to approve the Asset Sale Proposal at the time of the Special Meeting (the “Adjournment Proposal”).
|
| 2023-03-20 |
详情>>
业绩披露：
2023年中报每股收益-0.45美元,归母净利润-2195.5万美元,同比去年增长-341.4%
|
| 2022-12-21 |
股东大会：
将于2023-01-31召开股东大会
会议内容 ▼▲
- 1.To elect Hamid Erfanian, Bradley L. Radoff, and Mary Tagliaferri, M.D. to the Company’s Board of Directors (the “Board”) to hold office for a term ending as of our 2023 annual meeting of shareholders, and until each such director’s successor is elected and qualified;
2.To approve, by a nonbinding advisory vote, the compensation of the Company’s Named Executive Officers (the “Advisory Proposal”);
3.To ratify the Company’s appointment of EisnerAmper LLP to serve as the Company’s independent registered public accounting firm for the Company’s fiscal year ending July 31, 2023 (the “Auditor Proposal”);
4.To transact such other business as may properly come before the Annual Meeting.
|
| 2022-12-12 |
详情>>
业绩披露：
2023年一季报每股收益-0.22美元,归母净利润-1063.5万美元,同比去年增长-358.6%
|
| 2022-12-12 |
财报披露：
美东时间 2022-12-12 盘后发布财报
|
| 2022-03-01 |
股东大会：
将于2022-03-31召开股东大会
会议内容 ▼▲
- 1.To amend the Company’s certificate of incorporation, as amended (“Certificate of Incorporation”), as indicated in the six sub-proposals below (collectively, the “Charter Proposals”). The Charter Proposals are being presented separately in accordance with U.S. Securities and Exchange Commission (“SEC”) guidance to give shareholders the opportunity to present their separate views on important corporate governance provisions.(a)to change the purpose of the Company to carry on any lawful business;(b)to declassify the Company’s board of directors (the “Board”);(c)to remove Article 7 regarding the Company’s first accounting period for 1976;(d)to change the required shareholder vote for approval of mergers, asset sales, and dissolution from two-thirds vote to majority vote;(e)to change the required shareholder vote for amendments to the Certificate of Incorporation to a majority vote;(f)to change the required vote for amendments to our Amended and Restated By-Laws (“By-Laws”) to either majority board approval or majority shareholder approval.
2.If the shareholders approve Proposal 1(b) to eliminate classification of the Board, to elect Hamid Erfanian and Bradley L. Radoff each to serve on our Board for a term ending as of our 2022 annual meeting of shareholders, and until each such director’s successor is duly elected and qualified, or if the shareholders do not approve Proposal 1(b) to eliminate classification of the Board, to elect Hamid Erfanian and Bradley L. Radoff each to serve as the Class I Directors, to hold office for a term of three (3) years or until their successors have been duly elected and qualified (the “Director Proposal”);
3.To approve, by a nonbinding advisory vote, the compensation of the Company’s Named Executive Officers (the “Advisory Proposal”);
4.To ratify the Company’s appointment of EisnerAmper LLP to serve as the Company’s independent registered public accounting firm for the Company’s fiscal year ending July 31, 2022 (the “Auditor Proposal”);
5.To transact such other business as may properly come before the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-11-27 |
股东大会：
将于2021-01-04召开股东大会
会议内容 ▼▲
- 1.to elect (i) Elazar Rabbani, Ph.D. and Ian Walters, M.D. to the Company’s Board of Directors (the “Board”) as Class III Directors, to hold office for a term of three (3) years or until their successors have been duly elected and qualified, and (ii) Mary Tagliaferri, M.D. to the Board as a Class II Director, to hold office for a term of two (2) years or until her successor has been duly elected and qualified;
2.to approve, by a nonbinding advisory vote, the compensation of the Company’s Named Executive Officers;
3.to ratify the Company’s appointment of EisnerAmper LLP to serve as the Company’s independent registered public accounting firm for the Company’s fiscal year ending July 31, 2021;
4.to approve the amendment and restatement of the Company’s Amended and Restated 2011 Incentive Plan, including an increase in the number of shares of common stock authorized for grant under such plan;
5.to transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2020-03-10 |
复牌提示：
2020-03-10 09:34:00 停牌，复牌日期 2020-03-10 09:39:28
|
| 2018-11-21 |
股东大会：
将于2019-01-03召开股东大会
会议内容 ▼▲
- 1.to elect to the Company’s Board of Directors (the “Board”) as Class I Directors, Gregory M. Bortz and Dov Perlysky to hold office for a term of three (3) years or until his successor has been duly elected and qualified;
2.to approve, by a nonbinding advisory vote, the compensation of the Company’s Named Executive Officers;
3.to ratify the Company’s appointment of EisnerAmper LLP to serve as the Company’s independent registered public accounting firm for the Company’s fiscal year ending July 31, 2019;
4.to transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2017-11-22 |
股东大会：
将于2018-01-05召开股东大会
会议内容 ▼▲
- 1.to elect to the Company’s Board of Directors (the “Board”) as Class III Director, Dr. Elazar Rabbani, Ph.D., to hold office for a term of three (3) years or until his successor has been duly elected and qualified;
2.to approve, by a nonbinding advisory vote, the compensation of the Company’s Named Executive Officers;
3.to recommend, by a nonbinding advisory vote, the frequency of future advisory votes on the compensation of the Company’s named executive officers;
4.to approve the amendment and restatement of the Company’s 2011 Incentive Plan, including an increase in the number of shares of common stock authorized for grant under such plan;
5.to ratify the Company’s appointment of EisnerAmper LLP to serve as the Company’s independent registered public accounting firm for the Company’s fiscal year ending July 31, 2018;
6.to transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2016-11-23 |
股东大会：
将于2017-01-05召开股东大会
会议内容 ▼▲
- 1.to elect to the Company’s Board of Directors (the “Board”) as Class II Directors, Mr. Barry W. Weiner and Dr. Bruce A. Hanna, Ph.D., each to hold office for a term of three (3) years or until their respective successors have been duly elected and qualified;
2.to approve, in a nonbinding advisory vote, the compensation of the Company’s Named Executive Officers;
3.to ratify the Company’s appointment of EisnerAmper LLP to serve as the Company’s independent registered public accounting firm for the Company’s fiscal year ending July 31, 2017;
4.to transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2015-12-10 |
股东大会：
将于2016-01-06召开股东大会
会议内容 ▼▲
- 1.to elect to the Company’s Board of Directors (the “Board”) as Class I Directors, Gregory M. Bortz and Dov Perlysky, to hold office for a term of three (3) years or until their respective successors have been duly elected and qualified;
2.to approve, in a nonbinding advisory vote, the compensation of the Company’s Named Executive Officers;
3.to ratify the Company’s appointment of EisnerAmper LLP to serve as the Company’s independent registered public accounting firm for the Company’s fiscal year ending July 31, 2016;
4.to transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|